Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 7, 2007, Pages 871-877

  Barrington, C ^a   Moreno, L ^b   Kerrigan, D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Centro de Orientación e Investigación Integral COIN Santo Domingo   (Dominican Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; COUNSELING; DOMINICAN REPUBLIC; FEMALE; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SOCIAL SUPPORT;

ADULT; AIDS VACCINES; DOMINICAN REPUBLIC; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREJUDICE; PROSTITUTION; QUALITATIVE RESEARCH; QUESTIONNAIRES; STEREOTYPING;

EID: 34548073892     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701203295     Document Type: Article

References (20)

1. Buchbinder, S.P., Metch, B., Holte, S.E., Scheer, S., Coletti, A., & Vittinghoff, E. (2004). Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes, 36(1), 604-12.
2. Chesney, M.A., Lurie, P., & Coates, T.J. (1995). Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 9(1), 30-35.
3. Crosby, R.A., Holtgrave, D.R., Bryant, L., & Frew, P.M. (2004). Factors associated with the acceptance of an AIDS vaccine: an exploratory study. Preventive Medicine, 39(4), 804-8.
4. HVTN (2006). Possible Vaccine Outcomes. HIV Vaccine Trials Network (HVTN). Retrieved May 4 2006, 2006, from the World Wide Web: http://www.hvtn.org/science/outcomes.html.
5. IAVI (2006). Questions and Answers About Vaccines and AIDS. International AIDS Vaccine Initiative (IAVI). Retrieved May 4, 2006, from the World Wide Web: http://www.iavi.org/viewpage.cfm?aid=33.
6. Kilmarx, P.H., Ramjee, G., Kitayaporn, D., & Kunasol, P. (2001). Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia: experiences and recommendations. AIDS, 15(Suppl 5), S73-79.
7. Kiwanuka, N., Robb, M., Kigozi, G., Birx, D., Philips, J., Wabwire-Mangen, F., Wawer, M.J., Nalugoda, F., Sewankambo, N.K., Serwadda, D., & Gray, R.H. (2004). Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda. Journal of Acquired Immune Deficiency Syndromes, 36(2), 721-25.
8. Koblin, B.A., Holte, S., Lenderking, B., & Heagerty, P. (2000). Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. Journal of Acquired Immune Deficiency Syndromes, 24(5), 451-57.
9. Lurie, P., Bishaw, M., Chesney, M.A., Cooke, M., Fernandes, M.E., Hearst, N., Katongole-Mbidde, E., Koetsawang, S., Lindan, C.P., Mandel, J., et al. (1994). Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. JAMA, 271(4), 295-301.
10. McGrath, J.W., George, K., Svilar, G., Ihler, E., Mafigiri, D., Kabugo, M., & Mugisha, E. (2001). Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndromes, 27(4), 381-88.
11. Mills, E., Cooper, C., Guyatt, G., Gilchrist, A., Rachlis, B., Sulway, C., & Wilson, K. (2004). Barriers to participating in an HIV vaccine trial: a systematic review. AIDS, 18(17), 2235-42.
12. Newman, P.A., Duan, N., Rudy, E.T., Roberts, K.J., & Swendeman, D. (2004). Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV. Journal of Acquired Immune Deficiency Syndromes, 37(3), 1393-403.
13. Priddy, F.H., Cheng, A.C., Salazar, L.F., & Frew, P.M. (2006). Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US. International Journal of STD & AIDS, 17(2), 99-102.
14. Roberts, K.J., Newman, P.A., Duan, N., & Rudy, E.T. (2005). HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion. Journal of the National Medical Association, 97(12), 1662-671.
15. Rudy, E.T., Newman, P.A., Duan, N., Kelly, E.M., Roberts, K.J., & Seiden, D.S. (2005). HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake. AIDS Education and Prevention, 17(3), 253-67.
16. Sahay, S., Mehendale, S., Sane, S., Brahme, R., Brown, A., Charron, K., Beyrer, C., Bollinger, R., & Paranjape, R. (2005). Correlates of HIV vaccine trial participation: an Indian perspective. Vaccine, 23(11), 1351-358.
17. Salazar, L.F., Holtgrave, D., Crosby, R.A., Frew, P., & Peterson, J.L. (2005). Issues related to gay and bisexual men's acceptance of a future AIDS vaccine. International Journal of STD & AIDS, 16(8), 546-48.
18. Sheon, A.R., Wagner, L., McElrath, M.J., Keefer, M.C., Zimmerman, E., Israel, H., Berger, D., & Fast, P. (1998). Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial. Journal of the Acquired Immune Deficiency Syndromes and Human Retrovirology, 19(5), 519-26.
19. Smit, J., Middelkoop, K., Myer, L., Seedat, S., Bekker, L.G., & Stein, D.J. (2006). Willingness to participate in HIV vaccine research in a peri-urban South African community. International Journal of STD and AIDS, 17(3), 176-79.
20. Strauss, R.P., Sengupta, S., Kegeles, S., McLellan, E., Metzger, D., Eyre, S., Khanani, F., Emrick, C.B., & MacQueen, K. M. (2001). Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes, 26(1), 63-71.